Preventing bronchopulmonary dysplasia: new tools for an old challenge

Area of Science:

• Neonatology
• Pulmonology
• Biomarker Discovery

Background:

• Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease in preterm infants.
• Current preventive and treatment strategies for BPD are limited, posing a significant therapeutic challenge.
• The development of BPD in premature infants is multifactorial, with unknown factors contributing alongside known risks.

Purpose of the Study:

• To identify prognostic biomarkers for early prediction of BPD in very low birth weight infants.
• To develop novel, complex in vitro human lung models for BPD research.
• To explore new therapeutic strategies for protecting the immature lung from injury.

Main Methods:

• Utilizing advancements in -omics technologies for biomarker identification.
• Developing sophisticated 3D organoid models of the human lung.
• Applying principles of regenerative medicine for therapeutic development.

Main Results:

• Identification of potential prognostic biomarkers for BPD risk.
• Establishment of advanced in vitro models for studying BPD pathophysiology.
• Exploration of novel therapeutic avenues based on recent scientific progress.

Conclusions:

• New approaches involving biomarkers and advanced lung models offer opportunities to address BPD's complex pathophysiology.
• Early prediction and targeted therapies are crucial for managing BPD in premature infants.
• Integration of -omics, organoids, and regenerative medicine holds promise for developing effective BPD treatments.